Department of Cardiology, Tulane University, New Orleans, Louisiana, USA.
Clin Cardiol. 2024 May;47(5):e24282. doi: 10.1002/clc.24282.
Ultra-low contrast administration during coronary angiography has been previously shown to be feasible and safe among patients with stable chronic kidney disease. In the present study, we investigate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury (AKI).
The study was a retrospective single-center evaluation of hospitalized patients who had AKI and required coronary angiography. Ultra-low contrast use was defined as ≤18 mL of contrast media.
The cohort consisted of a case series of eight inpatients with AKI who required coronary angiography. The mean age was 57 (±16) years and half were females. All patients had chronic kidney disease with a mean baseline estimated glomerular filtration rate of 34 (±17) mL/min/1.73 m. The mean creatinine before angiography was 3 (±1) mg/dL and volume of contrast administered was 14 (±4) mL. One patient had a 0.1 mg/dL increase in creatinine during admission, and no patients had further AKI up to 1-week postprocedure.
The current data suggest that ultra-low contrast coronary angiography can be safely performed in patients with pre-existing AKI The study should be viewed as hypothesis-generating due to its small sample size. A larger cohort is required to validate the results.
在患有稳定型慢性肾病的患者中,冠状动脉造影时进行超低对比剂管理先前已被证明是可行且安全的。在本研究中,我们研究了预先存在急性肾损伤(AKI)的患者进行超低对比冠状动脉造影的安全性。
该研究是对需要冠状动脉造影的患有 AKI 的住院患者进行的回顾性单中心评估。超低对比剂的使用定义为≤18mL 的造影剂。
该队列包括 8 名需要冠状动脉造影的 AKI 住院患者的病例系列。平均年龄为 57(±16)岁,半数为女性。所有患者均患有慢性肾脏病,基线估算肾小球滤过率(eGFR)平均为 34(±17)mL/min/1.73m。造影前的平均肌酐为 3(±1)mg/dL,使用的造影剂体积为 14(±4)mL。1 名患者在住院期间肌酐增加了 0.1mg/dL,并且在术后 1 周内没有患者发生进一步的 AKI。
目前的数据表明,预先存在 AKI 的患者可以安全地进行超低对比冠状动脉造影。由于样本量小,该研究应被视为产生假说。需要更大的队列来验证结果。